PhagoMed re-selected for Gold Track Acceleration program
PhagoMed successfully completed Phase 1 of the Gold Track program, the premier European life sciences accelerator, and presented its results to the Gold Track Executive Council on October 7th. Following a vote of the Executive Council, PhagoMed was re-selected as a member of the Gold Track program for the next program phase.
The company joins five other visionary healthcare start-ups in the current cohort of the program. Each start-up had to prove the viability of their innovations and business plans in the competitive EIT Health Gold Track workshop. As part of the Gold Track program PhagoMed will once again receive individualized and tailored mentoring by industry giants, to support the further acceleration of our research programs and our fundraising efforts.
The Gold Track program selects between 10 and 15 European Lifescience companies every year. These companies receive world-class mentoring and tailor-made exposure to potential investors and industry partners around the world. For more information on the Gold Track program, please follow this link.